Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes - Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

American Heart Journal

Volumn 164, Issue 3, 2012, Pages

  Cornel, Jan H ^a   Becker, Richard C ^b   Goodman, Shaun G ^c   Husted, Steen ^d   Katus, Hugo ^e   Santoso, Anwar ^f   Steg, Gabriel ^g,h,i   Storey, Robert F ^j   Vintila, Marius ^k   Sun, Jie L ^b   Horrow, Jay ^l   Wallentin, Lars ^m   Harrington, Robert ^b   James, Stefan ^m  

^a Location Alkmaar   (Netherlands)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f UNIVERSITY OF INDONESIA   (Indonesia)

^g INSERM   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ BICHAT HOSPITAL   (France)

^j UNIVERSITY OF SHEFFIELD   (United Kingdom)

^k CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^l ASTRAZENECA   (United Kingdom)

^m UPPSALA UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; TICAGRELOR;

ACUTE CORONARY SYNDROME; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; CORONARY STENT; DISEASE ASSOCIATION; FEMALE; HABITUAL SMOKING; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SMOKING; ST SEGMENT ELEVATION; STENT THROMBOSIS; STROKE;

EID: 84866325657     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.06.005     Document Type: Article

References (27)

1. J. Nowak, J.J. Murray, and J.A. Oates Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes Circulation 76 1987 6 14 (Pubitemid 17093187)
2. J. Hung, J.Y.T. Lam, and L. Lacoste Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin Circulation 92 1995 2432 2436
3. S.A. Harding, J. Sarma, and D.H. Josephs Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers Circulation 109 2004 1926 1929 (Pubitemid 38544479)
4. J.A. Ambrose, and R.S. Barua The pathophysiology of cigarette smoking and cardiovascular disease: an update J Am Coll Cardiol 2004 1731 1737 (Pubitemid 38622506)
5. C. Willi, P. Bodenmann, and W.A. Ghali Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis JAMA 298 2007 2654 2664 (Pubitemid 350254957)
6. N.R. Desai, J.L. Mega, and S. Jiang Interaction between cigarette smoking and clinical benefit of clopidogrel J Am Coll Cardiol 53 2009 1273 1278
7. K.P. Bliden, J. Dichiara, and L. Lawal The association of cigarette smoking with enhanced platelet inhibition by clopidogrel J Am Coll Cardiol 52 2008 531 533
8. S. Matetzky, B. Shenkman, and V. Guetta Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation 109 2004 3171 3175
9. L.A. Kroon Drug interactions with smoking Am J Health Syst Pharm 64 2007 1917 1921 (Pubitemid 47462906)
10. J.S. Berger, D.L. Bhatt, and S.R. Steinhubl Smoking, clopidogrel, and mortality in patients with established cardiovascular disease Circulation 120 2009 2337 2344
11. M. Sibbald, A.T. Yan, and W. Huang Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the global registry of acute coronary events Am Heart J 160 2010 855 861
12. P.A. Gurbel, K.P. Bliden, and K. Butler Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: The RESPOND study Circulation 121 2010 1188 1199
13. R.F. Storey, D. Angiolillo, and S. Patil Inhibitory Effects of Ticagrelor Compared to Clopidogrel on Platelet Function in Patients with Acute Coronary Syndromes: the PLATO PLATELET Substudy J Am Coll Cardiol 56 2010 1456 1462
14. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
15. 12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial Am Heart J 157 2009 599 605
16. G.I. Barbash, J. Reiner, and H.D. White Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the smoker's paradox from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries J Am Coll Cardiol 26 1995 1222 1229
17. J.M. van Werkhoven, J.D. Schuijf, and A.P. Pazhenkottil Influence of smoking on the prognostic value of cardiovascular computed tomography coronary angiography Eur Heart J 32 2011 365 370
18. D. Hasdai, K.N. Garrat, and D.E. Grill Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization N Engl J Med 336 1997 755 761 (Pubitemid 27113969)
19. R.T. van Domburg, W.S. op Reimer, and S.E. Hoeks Three life-years gained from smoking cessation after coronary artery bypass surgery: a 30-year follow-up study Am Heart J 156 2008 473 476
20. K.W. Baran, J.M. Lasala, and D.A. Cox A clinical risk score for the prediction of very late stent thrombosis in drug eluting stent patients EuroIntervention 6 2011 949 954
21. K. Goto, E. Nikolsky, and A.L. Lansky Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial) Am J Cardiol 108 2011 1387 1394
22. P.A. Gurbel, K.P. Bliden, and K. Butler Randomized double-blind assessment of the onset and offset of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study Circulation 120 2009 2577 2585
23. D.J. Angiolillo, A. Fernandez-Ortiz, and E. Bernardo Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives J Am Coll Cardiol 49 2007 1505 1516 (Pubitemid 46517957)
24. K.W. Park, J.J. Park, and K.H. Jeon Enhanced clopidogrel responsiveness in smokers: smokers' paradox is dependent on cytochrome P450 CYP1A2 status Arterioscler Thromb Vasc Biol 31 2011 665 671
25. W. Hochholzer, D. Trenk, and J.L. Mega Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy Am Heart J 162 2011 518 526
26. P.A. Gurbel, K.P. Bliden, and W. Samara Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST study J Am Coll Cardiol 46 2005 1820 1826 (Pubitemid 41579802)
27. I.J. Dahabreh, and D.M. Kent Index event bias as an explanation for the paradoxes of recurrence risk research JAMA 305 2011 822 823